$24.16
0.160.67%
Last update: Nov 6, 7:57 PM
Veracyte Inc (VCYT) Stock Price, Quote, News & History
VCYTNASDAQ
Veracyte (VCYT) stock tumbled 54% to a new 52-week low as weaker-than-expected Decipher Prostate test volumes overshadowed Q3 earnings beat.
You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.
Other companies in Veracyte’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Veracyte has a consensus price target of $50.21.
The stock price for Veracyte (NASDAQ: VCYT) is $24.2 last updated November 6, 2026 at 7:57 PM EST.
There are no upcoming dividends for Veracyte.
Veracyte does not have any upcoming earnings scheduled.
There is no upcoming split for Veracyte.
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher...
